Sookjin Lee
Chief Business Officer (CBO) | Ph.D.
A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.
Hereditary Cancer Germline Testing Across 21 European Countries: Why the Same Patient Can Receive a Different Diagnosis2026. 06. 21
How AI Prediction Tools Are Changing Rare Disease Diagnosis — ACMG PP3 Evidence Strength, REVEL, and 3Cnet2026. 06. 08
JAMA Asks: Why Does Diagnosis Still Take Five Years?2026. 05. 19
How Mobile Elements Cause Rare Disease — and How 3billion’s FindME Finds Them2026. 05. 18
Which Children with Motor Speech Disorders Should Be Prioritised for Genetic Testing?2026. 05. 15
[Clinical Review] Why WGS Achieves up to 44.4% Diagnostic Yield in NDD: Insights from a 100-Family Italian Study2026. 02. 20